Olczyk, P.; Koprowski, R.; Komosinska-Vassev, K.; Jura-Półtorak, A.; Winsz-Szczotka, K.; Kuźnik-Trocha, K.; Mencner, Ł.; Telega, A.; Ivanova, D.; Olczyk, K.
Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir. Molecules 2017, 22, 1274.
https://doi.org/10.3390/molecules22081274
AMA Style
Olczyk P, Koprowski R, Komosinska-Vassev K, Jura-Półtorak A, Winsz-Szczotka K, Kuźnik-Trocha K, Mencner Ł, Telega A, Ivanova D, Olczyk K.
Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir. Molecules. 2017; 22(8):1274.
https://doi.org/10.3390/molecules22081274
Chicago/Turabian Style
Olczyk, Paweł, Robert Koprowski, Katarzyna Komosinska-Vassev, Agnieszka Jura-Półtorak, Katarzyna Winsz-Szczotka, Kornelia Kuźnik-Trocha, Łukasz Mencner, Alicja Telega, Diana Ivanova, and Krystyna Olczyk.
2017. "Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir" Molecules 22, no. 8: 1274.
https://doi.org/10.3390/molecules22081274
APA Style
Olczyk, P., Koprowski, R., Komosinska-Vassev, K., Jura-Półtorak, A., Winsz-Szczotka, K., Kuźnik-Trocha, K., Mencner, Ł., Telega, A., Ivanova, D., & Olczyk, K.
(2017). Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir. Molecules, 22(8), 1274.
https://doi.org/10.3390/molecules22081274